Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes

Neuropeptides

Volumn 46, Issue 6, 2012, Pages 359-366

  Rosmaninho Salgado, Joana ^a   Cortez, Vera ^a   Estrada, Marta ^a   Santana, Magda M ^a,b   Gonçalves, Alexandra ^a   Marques, Ana Patrícia ^a   Cavadas, Cláudia ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Adipogenesis; Intracellular pathways; Lipid accumulation; Neuropeptide Y

Indexed keywords

N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ARGININE; BENZAZEPINES; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORING AGENTS; LIPID METABOLISM; MICE; NEUROPEPTIDE Y; PPAR GAMMA; PROTEIN KINASE INHIBITORS; RECEPTORS, NEUROPEPTIDE Y;

MURINAE;

EID: 84869870468     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.08.006     Document Type: Article

References (48)

1. Baker S.B., Cohen M., Kuo L., Johnson M., Al-Attar A., Zukowska Z. The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Plast. Reconstr. Surg. 2009, 123(2):486-492.
2. Baltazi M., Katsiki N., Savopoulos C., Iliadis F., Koliakos G., Hatzitolios A.I. Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study. Am. J. Cardiovasc. Dis. 2011, 1(1):48-59.
3. Baranowska B., Wolinska-Witort E., Martynska L., Chmielowska M., Baranowska-Bik A. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol. Lett. 2005, 26(4):293-296.
4. Castan I., Valet P., Voisin T., Quideau N., Laburthe M., Lafontan M. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology 1992, 131(4):1970-1976.
5. Cho M., Park S., Gwak J., Kim D.E., Yea S.S., Shin J.G., Oh S. Bisindoylmaleimide I suppresses adipocyte differentiation through stabilization of intracellular beta-catenin protein. Biochem. Biophys. Res. Commun. 2008, 367(1):195-200.
6. Choi S.M., Tucker D.F., Gross D.N., Easton R.M., Dipilato L.M., Dean A.S., Monks B.R., Birnbaum M.J. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol. Cell. Biol. 2010, 30(21):5009-5020.
7. 5 receptor. J. Clin. Invest. 1998, 102(12):2136-2145.
8. Daniels A.J., Grizzle M.K., Wiard R.P., Matthews J.E., Heyer D. Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist. Regul. Pept. 2002, 106(1-3):47-54.
9. Dryden S., Pickavance L., Frankish H.M., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 1995, 690(2):185-188.
10. Farmer S.R. Regulation of PPARgamma activity during adipogenesis. Int. J. Obes. (Lond.) 2005, 29(Suppl. 1):S13-S16.
11. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004, 53(Suppl 1):S43-50.
12. Fricke K., Heitland A., Maronde E. Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes. Endocrinology 2004, 145(11):4940-4947.
13. Gao J.Z., Zheng R.D., Wang C.B., Ying Y.Q., Luo X.P. Effects of PI3K inhibitor LY294002 on the differentiation of mouse preadipocytes and the expression of C/EBPalpha and PPARgamma. Zhongguo Dang Dai Er Ke Za Zhi 2011, 13(10):823-826.
14. Gericke M.T., Kosacka J., Koch D., Nowicki M., Schroder T., Ricken A.M., Nieber K., Spanel-Borowski K. Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line. Br. J. Pharmacol. 2009, 157(4):620-632.
15. Gong H.X., Guo X.R., Fei L., Guo M., Liu Q.Q., Chen R.H. Lipolysis and apoptosis of adipocytes induced by neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides in obese rats. Acta Pharmacol. Sin. 2003, 24(6):569-575.
16. Grouzmann E., Cressier F., Walker P., Hofbauer K., Waeber B., Brunner H.R. Interactions between NPY and its receptor: assessment using ant-NPY antibodies. Regul. Pept. 1994, 54(2-3):439-444.
17. Han R., Kitlinska J.B., Munday W.R., Gallicano G.I., Zukowska Z. Stress hormone epinephrine enhances adipogenesis in murine embryonic stem cells by up-regulating the neuropeptide y system. PLoS One 2012, 7(5):e36609.
18. Ishihara A., Kanatani A., Mashiko S., Tanaka T., Hidaka M., Gomori A., Iwaasa H., Murai N., Egashira S., Murai T., Mitobe Y., Matsushita H., Okamoto O., Sato N., Jitsuoka M., Fukuroda T., Ohe T., Guan X., Macneil D.J., Van Der Ploeg L.H., Nishikibe M., Ishii Y., Ihara M., Fukami T. A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. Proc. Natl. Acad. Sci. USA 2006, 103(18):7154-7158.
19. Kim S.P., Ha J.M., Yun S.J., Kim E.K., Chung S.W., Hong K.W., Kim C.D., Bae S.S. Transcriptional activation of peroxisome proliferator-activated receptor-gamma requires activation of both protein kinase A and Akt during adipocyte differentiation. Biochem. Biophys. Res. Commun. 2010, 399(1):55-59.
20. Kos K., Harte A.L., James S., Snead D.R., O'hare J.P., Mcternan P.G., Kumar S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am. J. Physiol. Endocrinol. Metab. 2007, 293(5):E1335-1340.
21. Kuo L.E., Kitlinska J.B., Tilan J.U., Li L., Baker S.B., Johnson M.D., Lee E.W., Burnett M.S., Fricke S.T., Kvetnansky R., Herzog H., Zukowska Z. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 2007, 13(7):803-811.
22. Labelle M., Boulanger Y., Fournier A., St Pierre S., Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides 1997, 18(6):801-808.
23. Lin E.J., Sainsbury A., Lee N.J., Boey D., Couzens M., Enriquez R., Slack K., Bland R., During M.J., Herzog H. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity. Endocrinology 2006, 147(11):5094-5101.
24. Liu M., Hu P.A., Ding K.X. Neuropeptide Y promotes the proliferation and differentiation of 3T3-L1 preadipocytes. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011, 27(6):605-607.
25. Margareto J., Aguado M., Oses-Prieto J.A., Rivero I., Monge A., Aldana I., Marti A., Martinez J.A. A new NPY-antagonist strongly stimulates apoptosis and lipolysis on white adipocytes in an obesity model. Life Sci. 2000, 68(1):99-107.
26. Margareto J., Rivero I., Monge A., Aldana I., Marti A., Martinez J.A. Changes in UCP2, PPARgamma2, and c/EBPalpha gene expression induced by a neuropeptide Y (NPY) related receptor antagonist in overweight rats. Nutr. Neurosci. 2002, 5(1):13-17.
27. Martinez J.A., Aguado M., Fruhbeck G. Interactions between leptin and NPY affecting lipid mobilization in adipose tissue. J. Physiol. Biochem. 2000, 56(1):1-8.
28. Mashiko S., Ishihara A., Iwaasa H., Moriya R., Kitazawa H., Mitobe Y., Ito J., Gomori A., Matsushita H., Takahashi T., Macneil D.J., Van Der Ploeg L.H., Fukami T., Kanatani A. Effects of a novel Y5 antagonist in obese mice. combination with food restriction or sibutramine. Obesity (Silver Spring) 2008, 16(7):1510-1515.
29. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50(1):143-150.
30. Petersen R.K., Madsen L., Pedersen L.M., Hallenborg P., Hagland H., Viste K., Doskeland S.O., Kristiansen K. Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol. Cell. Biol. 2008, 28(11):3804-3816.
31. Qiu J., Ni Y.H., Chen R.H., Ji C.B., Liu F., Zhang C.M., Gao C.L., Chen X.H., Tong M.L., Chi X., Zhou X.Y., Guo X.R. Gene expression profiles of adipose tissue of obese rats after central administration of neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides by cDNA microarrays. Peptides 2008, 29(11):2052-2060.
32. Ramsay T.G. Fat cells. Endocrinol. Metab. Clin. North Am. 1996, 25(4):847-870.
33. Ramsay T.G. Porcine leptin inhibits lipogenesis in porcine adipocytes. J. Anim. Sci. 2003, 81(12):3008-3017.
34. Rosmaninho-Salgado J., Marques A., Estrada M., Santana M., Cortez V., Grouzmann E., Cavadas C. Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-γ expression. Peptides 2012.
35. Sahu A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 1998, 139(2):795-798.
36. Serradeil-Le Gal C., Lafontan M., Raufaste D., Marchand J., Pouzet B., Casellas P., Pascal M., Maffrand J.P., Le Fur G. Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes. FEBS Lett. 2000, 475(2):150-156.
37. Shaw J.L., Gackenheimer S.L., Gehlert D.R. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding. J. Chem. Neuroanat. 2003, 26(3):179-193.
38. Shi Y.C., Lin S., Castillo L., Aljanova A., Enriquez R.F., Nguyen A.D., Baldock P.A., Zhang L., Bijker M.S., Macia L., Yulyaningsih E., Zhang H., Lau J., Sainsbury A., Herzog H. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) 2011, 19(11):2137-2148.
39. Shimada K., Ohno Y., Okamatsu-Ogura Y., Suzuki M., Kamikawa A., Terao A., Kimura K. Neuropeptide Y activates phosphorylation of ERK and STAT3 in stromal vascular cells from brown adipose tissue, but fails to affect thermogenic function of brown adipocytes. Peptides 2012, 34(2):336-342.
40. Silva A.P., Xapelli S., Grouzmann E., Cavadas C. The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 2005, 4(4):331-347.
41. Tao Y., Maegawa H., Ugi S., Ikeda K., Nagai Y., Egawa K., Nakamura T., Tsukada S., Nishio Y., Maeda S., Kashiwagi A. The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes. Endocrinology 2006, 147(4):1685-1696.
42. Turtzo L.C., Marx R., Lane M.D. Cross-talk between sympathetic neurons and adipocytes in coculture. Proc. Natl. Acad. Sci. USA 2001, 98(22):12385-12390.
43. Valet P., Berlan M., Beauville M., Crampes F., Montastruc J.L., Lafontan M. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. J. Clin. Invest. 1990, 85(1):291-295.
44. Van Epps-Fung M., Gupta K., Hardy R.W., Wells A. A role for phospholipase C activity in GLUT4-mediated glucose transport. Endocrinology 1997, 138(12):5170-5175.
45. Wang C., Yang N., Wu S., Liu L., Sun X., Nie S. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet. Horm. Metab. Res. 2007, 39(4):262-267.
46. Watanabe M., Inukai K., Katagiri H., Awata T., Oka Y., Katayama S. Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2003, 300(2):429-436.
47. Yang K., Guan H., Arany E., Hill D.J., Cao X. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J. 2008, 22(7):2452-2464.
48. Zhou Y., Wang D., Li F., Shi J., Song J. Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation. Int. J. Biochem. Cell Biol. 2006, 38(12):2151-2163.